Skip to main content
Erschienen in: Surgical Endoscopy 6/2017

22.09.2016

Mortality after esophagectomy is heavily impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample

verfasst von: Hans F. Fuchs, Cristina R. Harnsberger, Ryan C. Broderick, David C. Chang, Bryan J. Sandler, Garth R. Jacobsen, Michael Bouvet, Santiago Horgan

Erschienen in: Surgical Endoscopy | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

The effects of hospital volume on in-hospital mortality after esophageal resection are disputed in the literature. We sought to analyze treatment effects in patient subpopulations that undergo esophagectomy for cancer based on hospital volume.

Methods

We performed a retrospective analysis of the Nationwide Inpatient Sample from 1998 to 2011. Patients who underwent open or laparoscopic transhiatal and transthoracic esophageal resection were identified using ICD-9 codes. Patients <18 years and those with peritoneal disease were excluded. Multivariate logistic regression analyses were used with mortality as the independent variable to evaluate the effect of low (<6), intermediate (6–19), and high (20) hospital volume of esophagectomies. These analyses were repeated in different subsets of patients to determine whether hospital volume affected mortality depending on the subpopulation evaluated. Subgroups were created depending on age, race, gender, operative approach, comorbidities, and tumor pathology.

Results

A total of 23,751 patients were included. The overall perioperative mortality rate was 7.7 % (low volume: 11.4 %; intermediate volume: 8.39 %, high volume: 4.01 %), and multivariate analysis revealed that high hospital volume had a protective effect (OR 0.54, 95 % CI 0.45–0.65). On subgroup analyses for low- and intermediate-volume hospitals, mortality was uniformly elevated for the subpopulations when comparing to high-volume hospitals (p < 0.05). There was no difference in mortality between low- and medium-volume hospitals and between subgroups.

Conclusion

No lower mortality risk subgroup could be identified in this nationwide collective. This analysis emphasizes that perioperative mortality after esophagectomy for cancer is lower in high-volume hospitals.
Literatur
1.
Zurück zum Zitat Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Hölscher AH (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 254(1):67–72CrossRefPubMed Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Hölscher AH (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 254(1):67–72CrossRefPubMed
2.
Zurück zum Zitat Pech O, Manner H, Ell C, Bollschweiler E, Hölscher AH (2013) Reply to letter: “For patients with early esophageal cancer endoscopic mucosa resection is not the end of the story!”. Ann Surg 257(6):e22–e23CrossRefPubMed Pech O, Manner H, Ell C, Bollschweiler E, Hölscher AH (2013) Reply to letter: “For patients with early esophageal cancer endoscopic mucosa resection is not the end of the story!”. Ann Surg 257(6):e22–e23CrossRefPubMed
3.
Zurück zum Zitat Metzger R, Lorenz D, Gockel I, Origer J, Plum PS, Junginger T, Drebber U, Hansen T, Krümpelmann K, Fisseler-Eckhoff A, Lang H, Hölscher AH, Bollschweiler E (2013) pT2 adenocarcinoma of the esophagus: early or advanced cancer? Ann Thorac Surg 96(5):1840–1845CrossRefPubMed Metzger R, Lorenz D, Gockel I, Origer J, Plum PS, Junginger T, Drebber U, Hansen T, Krümpelmann K, Fisseler-Eckhoff A, Lang H, Hölscher AH, Bollschweiler E (2013) pT2 adenocarcinoma of the esophagus: early or advanced cancer? Ann Thorac Surg 96(5):1840–1845CrossRefPubMed
4.
Zurück zum Zitat Fuchs HF, Hölscher AH (2014) Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer. Zentralbl Chir 139(1):32–36 (Review. German) CrossRefPubMed Fuchs HF, Hölscher AH (2014) Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer. Zentralbl Chir 139(1):32–36 (Review. German) CrossRefPubMed
5.
Zurück zum Zitat Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR (2014) Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer—a propensity score matched analysis. Eur J Cancer 50(17):2950–2957CrossRefPubMed Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR (2014) Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer—a propensity score matched analysis. Eur J Cancer 50(17):2950–2957CrossRefPubMed
6.
Zurück zum Zitat van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A, CROSS Group (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084CrossRefPubMed van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A, CROSS Group (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366(22):2074–2084CrossRefPubMed
7.
Zurück zum Zitat Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232(2):225–232CrossRefPubMedPubMedCentral Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232(2):225–232CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Igaki H, Tachimori Y, Kato H (2004) Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 239(4):483–490CrossRefPubMedPubMedCentral Igaki H, Tachimori Y, Kato H (2004) Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 239(4):483–490CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Mariette C, Taillier G, Van Seuningen I, Triboulet JP (2004) Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg 78(4):1177–1183CrossRefPubMed Mariette C, Taillier G, Van Seuningen I, Triboulet JP (2004) Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg 78(4):1177–1183CrossRefPubMed
10.
Zurück zum Zitat Law S, Wong KH, Kwok KF, Chu KM, Wong J (2004) Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240(5):791–800CrossRefPubMedPubMedCentral Law S, Wong KH, Kwok KF, Chu KM, Wong J (2004) Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240(5):791–800CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256(1):95–103CrossRefPubMedPubMedCentral Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256(1):95–103CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Osugi H, Takemura M, Higashino M, Takada N, Lee S, Kinoshita H (2003) A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg 90(1):108–113 (Erratum in: Br J Surg 90(6):764) CrossRefPubMed Osugi H, Takemura M, Higashino M, Takada N, Lee S, Kinoshita H (2003) A comparison of video-assisted thoracoscopic oesophagectomy and radical lymph node dissection for squamous cell cancer of the oesophagus with open operation. Br J Surg 90(1):108–113 (Erratum in: Br J Surg 90(6):764) CrossRefPubMed
13.
Zurück zum Zitat Coker AM, Barajas-Gamboa JS, Cheverie J, Jacobsen GR, Sandler BJ, Talamini MA, Bouvet M, Horgan S (2014) Outcomes of robotic-assisted transhiatal esophagectomy for esophageal cancer after neoadjuvant chemoradiation. J Laparoendosc Adv Surg Tech A 24(2):89–94CrossRefPubMed Coker AM, Barajas-Gamboa JS, Cheverie J, Jacobsen GR, Sandler BJ, Talamini MA, Bouvet M, Horgan S (2014) Outcomes of robotic-assisted transhiatal esophagectomy for esophageal cancer after neoadjuvant chemoradiation. J Laparoendosc Adv Surg Tech A 24(2):89–94CrossRefPubMed
14.
Zurück zum Zitat Zhang J, Wang R, Liu S, Luketich JD, Chen S, Chen H, Schuchert MJ (2012) Refinement of minimally invasive esophagectomy techniques after 15 years of experience. J Gastrointest Surg 16(9):1768–1774CrossRefPubMed Zhang J, Wang R, Liu S, Luketich JD, Chen S, Chen H, Schuchert MJ (2012) Refinement of minimally invasive esophagectomy techniques after 15 years of experience. J Gastrointest Surg 16(9):1768–1774CrossRefPubMed
15.
Zurück zum Zitat Schröder W, Hölscher AH, Bludau M, Vallböhmer D, Bollschweiler E, Gutschow C (2010) Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit. World J Surg 34(4):738–743CrossRefPubMed Schröder W, Hölscher AH, Bludau M, Vallböhmer D, Bollschweiler E, Gutschow C (2010) Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit. World J Surg 34(4):738–743CrossRefPubMed
16.
Zurück zum Zitat Fuchs HF, Broderick RC, Harnsberger CR, Divo FA, Coker AM, Jacobsen GR, Sandler BJ, Bouvet M, Horgan S (2016) Intraoperative endoscopic botox injection during total esophagectomy prevents the need for pyloromyotomy or dilatation. J Laparoendosc Adv Surg Tech A 26(6):433–438. doi:10.1089/lap.2015.0575 CrossRefPubMed Fuchs HF, Broderick RC, Harnsberger CR, Divo FA, Coker AM, Jacobsen GR, Sandler BJ, Bouvet M, Horgan S (2016) Intraoperative endoscopic botox injection during total esophagectomy prevents the need for pyloromyotomy or dilatation. J Laparoendosc Adv Surg Tech A 26(6):433–438. doi:10.​1089/​lap.​2015.​0575 CrossRefPubMed
17.
Zurück zum Zitat Fuchs HF, Harnsberger CR, Broderick RC, Chang DC, Sandler BJ, Jacobsen GR, Bouvet M, Horgan S (2016) Simple preoperative risk scale accurately predicts perioperative mortality following esophagectomy for malignancy. Dis Esophagus. doi:10.1111/dote.12451 PubMed Fuchs HF, Harnsberger CR, Broderick RC, Chang DC, Sandler BJ, Jacobsen GR, Bouvet M, Horgan S (2016) Simple preoperative risk scale accurately predicts perioperative mortality following esophagectomy for malignancy. Dis Esophagus. doi:10.​1111/​dote.​12451 PubMed
18.
Zurück zum Zitat Mitikiri ND, Reese ES, Hussain A, Onukwugha E, Pritchard D, Dubois R, Mullins CD (2013) The emerging relevance of heterogeneity of treatment effect in clinical care: a study using stage IV prostate cancer as a model. J Comp Eff Res 2(6):605–618CrossRefPubMed Mitikiri ND, Reese ES, Hussain A, Onukwugha E, Pritchard D, Dubois R, Mullins CD (2013) The emerging relevance of heterogeneity of treatment effect in clinical care: a study using stage IV prostate cancer as a model. J Comp Eff Res 2(6):605–618CrossRefPubMed
20.
Zurück zum Zitat Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619CrossRefPubMed
21.
Zurück zum Zitat Blencowe NS, Strong S, McNair AG, Brookes ST, Crosby T, Griffin SM, Blazeby JM (2012) Reporting of short-term clinical outcomes after esophagectomy: a systematic review. Ann Surg 255(4):658–666CrossRefPubMed Blencowe NS, Strong S, McNair AG, Brookes ST, Crosby T, Griffin SM, Blazeby JM (2012) Reporting of short-term clinical outcomes after esophagectomy: a systematic review. Ann Surg 255(4):658–666CrossRefPubMed
22.
Zurück zum Zitat Dimick JB, Cowan JA Jr, Ailawadi G, Wainess RM, Upchurch GR (2003) National variation in operative mortality rates for esophageal resection and the need for quality improvement. Arch Surg 138(12):1305–1309CrossRefPubMed Dimick JB, Cowan JA Jr, Ailawadi G, Wainess RM, Upchurch GR (2003) National variation in operative mortality rates for esophageal resection and the need for quality improvement. Arch Surg 138(12):1305–1309CrossRefPubMed
23.
Zurück zum Zitat Connors RC, Reuben BC, Neumayer LA, Bull DA (2007) Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg 205(6):735–740CrossRefPubMed Connors RC, Reuben BC, Neumayer LA, Bull DA (2007) Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17,395 patients. J Am Coll Surg 205(6):735–740CrossRefPubMed
24.
Zurück zum Zitat Kohn GP, Galanko JA, Meyers MO, Feins RH, Farrell TM (2009) National trends in esophageal surgery—are outcomes as good as we believe? J Gastrointest Surg 213(11):1900–1910 (discussion 1910–1912) CrossRef Kohn GP, Galanko JA, Meyers MO, Feins RH, Farrell TM (2009) National trends in esophageal surgery—are outcomes as good as we believe? J Gastrointest Surg 213(11):1900–1910 (discussion 1910–1912) CrossRef
25.
Zurück zum Zitat Lapar DJ, Stukenborg GJ, Lau CL, Jones DR, Kozower BD (2012) Differences in reported esophageal cancer resection outcomes between national clinical and administrative databases. J Thorac Cardiovasc Surg 144(5):1152–1157CrossRefPubMed Lapar DJ, Stukenborg GJ, Lau CL, Jones DR, Kozower BD (2012) Differences in reported esophageal cancer resection outcomes between national clinical and administrative databases. J Thorac Cardiovasc Surg 144(5):1152–1157CrossRefPubMed
26.
Zurück zum Zitat Hölscher AH, Bollschweiler E, Schneider PM, Siewert JR (1995) Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer 76(2):178–186CrossRefPubMed Hölscher AH, Bollschweiler E, Schneider PM, Siewert JR (1995) Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer 76(2):178–186CrossRefPubMed
27.
Zurück zum Zitat Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85(6):840–844CrossRefPubMed Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85(6):840–844CrossRefPubMed
28.
Zurück zum Zitat Bollschweiler E, Schröder W, Hölscher AH, Siewert JR (2000) Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg 87(8):1106–1110CrossRefPubMed Bollschweiler E, Schröder W, Hölscher AH, Siewert JR (2000) Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg 87(8):1106–1110CrossRefPubMed
29.
Zurück zum Zitat Kozower BD, Stukenborg GJ (2012) Hospital esophageal cancer resection volume does not predict patient mortality risk. Ann Thorac Surg 93(5):1690–1696 (discussion 1696–1698) CrossRefPubMed Kozower BD, Stukenborg GJ (2012) Hospital esophageal cancer resection volume does not predict patient mortality risk. Ann Thorac Surg 93(5):1690–1696 (discussion 1696–1698) CrossRefPubMed
30.
Zurück zum Zitat Metzger R, Bollschweiler E, Vallböhmer D, Maish M, DeMeester TR, Hölscher AH (2004) High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus 17(4):310–314CrossRefPubMed Metzger R, Bollschweiler E, Vallböhmer D, Maish M, DeMeester TR, Hölscher AH (2004) High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus 17(4):310–314CrossRefPubMed
31.
Zurück zum Zitat Milstein A, Galvin RS, Delbanco SF, Salber P, Buck CR (2001) Improving the safety of health care: the leapfrog initiative. Eff Clin Pract 3(6):313–316 (Erratum in: Eff Clin Pract 4(2):94) Milstein A, Galvin RS, Delbanco SF, Salber P, Buck CR (2001) Improving the safety of health care: the leapfrog initiative. Eff Clin Pract 3(6):313–316 (Erratum in: Eff Clin Pract 4(2):94)
32.
Zurück zum Zitat Munasinghe A, Markar SR, Mamidanna R, Darzi AW, Faiz OD, Hanna GB, Low DE (2015) Is it time to centralize high-risk cancer care in the United States? Comparison of outcomes of esophagectomy between England and the United States. Ann Surg 262(1):79–85CrossRefPubMed Munasinghe A, Markar SR, Mamidanna R, Darzi AW, Faiz OD, Hanna GB, Low DE (2015) Is it time to centralize high-risk cancer care in the United States? Comparison of outcomes of esophagectomy between England and the United States. Ann Surg 262(1):79–85CrossRefPubMed
33.
Zurück zum Zitat Klabunde CN, Warren JL, Legler JM (2002) Assessing comorbidity using claims data: an overview. Med Care 40(8):IV-26–IV-35 Klabunde CN, Warren JL, Legler JM (2002) Assessing comorbidity using claims data: an overview. Med Care 40(8):IV-26–IV-35
34.
Zurück zum Zitat Chang DC, Evans C, Parker J (2015) Conceptualizing administrative databases as screening tools for health system quality: rethinking the issue of data accuracy. JAMA Surg 150(1):5–6CrossRefPubMed Chang DC, Evans C, Parker J (2015) Conceptualizing administrative databases as screening tools for health system quality: rethinking the issue of data accuracy. JAMA Surg 150(1):5–6CrossRefPubMed
35.
Zurück zum Zitat Fuchs HF, Broderick RC, Harnsberger CR, Chang DC, Sandler BJ, Jacobsen GR, Horgan S (2015) Benefits of bariatric surgery do not reach obese men. J Laparoendosc Adv Surg Tech A 25(3):196–201CrossRefPubMed Fuchs HF, Broderick RC, Harnsberger CR, Chang DC, Sandler BJ, Jacobsen GR, Horgan S (2015) Benefits of bariatric surgery do not reach obese men. J Laparoendosc Adv Surg Tech A 25(3):196–201CrossRefPubMed
36.
Zurück zum Zitat Mariette C, Meunier B, Pezet D, Dalban C, Collet D, Thomas PA, Brigand C, Perniceni T, Carrere N, Bonnetain F, Piessen G (2015) Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicenter, open-label, randomized phase III controlled trial, the MIRO trial. J Clin Oncol 33(Suppl 3):abstr 5 Mariette C, Meunier B, Pezet D, Dalban C, Collet D, Thomas PA, Brigand C, Perniceni T, Carrere N, Bonnetain F, Piessen G (2015) Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicenter, open-label, randomized phase III controlled trial, the MIRO trial. J Clin Oncol 33(Suppl 3):abstr 5
Metadaten
Titel
Mortality after esophagectomy is heavily impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample
verfasst von
Hans F. Fuchs
Cristina R. Harnsberger
Ryan C. Broderick
David C. Chang
Bryan J. Sandler
Garth R. Jacobsen
Michael Bouvet
Santiago Horgan
Publikationsdatum
22.09.2016
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 6/2017
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-5251-9

Weitere Artikel der Ausgabe 6/2017

Surgical Endoscopy 6/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.